Presentation Information

[2P-783]A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection

○Kei Konishi1,2, Yoshiyuki Taoda3, Manabu Igarashi2, Takao Shishido1, Kazuya Yasuo3, Yasuko Orba4,5,2, Hirofumi Sawa4,5, Michihito Sasaki4,2, Akihiko Sato1,2,4 (1. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., 2. International Institute for Zoonosis Control, Hokkaido University, 3. Laboratory for Medicinal Chemistry Research, Shionogi & Co., Ltd., 4. Institute for Vaccine Research and Development, Hokkaido University, 5. One Health Research Center, Hokkaido University)

Password required to view

Please enter the password printed on your name card.
Online registrants can download your name card from the account page once payment has been successfully processed.

Comment

To browse or post comments, you must log in.Log in